Stockscreener 앱 받기
496.07
2.49%
12.04
시장 영업 전:
494.00
-2.07
-0.42%
Vertex Pharmaceuticals Inc 주식(VRTX)의 최신 뉴스
Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Vanguard Health Care ETF Outperforms VanEck Biotech on Returns, Yield, and Fees - The Motley Fool
Vertex Gears Up to Report Q2 Earnings: What Can Investors Expect? - TradingView
Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
Vertex Pharmaceuticals (VRTX) Projected to Announce Quarterly Earnings on Monday - MarketBeat
OMERS ADMINISTRATION Corp Has $8.39 Million Stock Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Lombard Odier Asset Management Switzerland SA Cuts Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Healthcare of Ontario Pension Plan Trust Fund Purchases 20,523 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Sei Investments Co. Sells 230,797 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Inc (VRTX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Vertex Pharmaceuticals Incorporated $VRTX Position Reduced by Cetera Investment Advisers - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by Bank of Nova Scotia - MarketBeat
Vertex Pharmaceuticals (VRTX) Q1 2026 Earnings Call Transcript - Fortune
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by Renaissance Technologies LLC - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Shares Bought by PNC Financial Services Group Inc. - MarketBeat
Arrowstreet Capital Limited Partnership Acquires 45,003 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharma stock trades near record levels as cystic fibrosis franchise drives earnings growth - AD HOC NEWS
Form 4 Vertex Pharmaceuticals Inc For: 24 July By Investing.com - Investing.com South Africa
Vertex Pharmaceuticals Inc (VRTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
VRTX|Vertex Pharmaceuticals Inc|Price:478.960|Chg%:+1.600 - TradingKey
VRTX|Vertex Pharmaceuticals Inc|Price:473.090| - TradingKey
VRTX|Vertex Pharmaceuticals Inc|Price:477.360|Chg%:+4.270 - TradingKey
Caxton Associates LLP Makes New Investment in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Gibbs Wealth Management Boosts Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharma stock trades near record territory as cystic fibrosis franchise drives earnings growth - AD HOC NEWS
CI Investments Inc. Reduces Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
First Trust Advisors LP Has $136.85 Million Stake in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Inc (VRTX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Vertex Pharmaceuticals (VRTX) EVP Amit Sachdev receives 8,251-share equity grant - Stock Titan
Vertex stock consolidates after strong Q1 2026 revenue growth - Ad-hoc-news.de
3 Healthcare Stocks with Competitive Advantages - Yahoo! Finance Canada
Missed AI, Memory Bull Run? Biotech May Be The Next Breakout Trade — But Retail Sentiment Has Never Been Lower - Yahoo Finance
Aureus Asset Management LLC Has $3.75 Million Stock Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Inc (VRTX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Vertex Pharmaceuticals (VRTX) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Yahoo Finance
Vertex was sole bidder in high-premium Crinetics acquisition - BioPharma Dive
Vertex Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Vertex was only bidder for Crinetics in year’s second-highest M&A premium - Endpoints News
Madison Asset Management LLC Boosts Stake in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Danica Pension Livsforsikringsaktieselskab Takes $11.67 Million Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex-Crinetics Pharmaceuticals deal faces Australian review - MLex
ABN Amro Investment Solutions Grows Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Andra AP fonden Has $10.67 Million Stock Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Former Vertex chief Jeff Leiden’s latest venture: a ‘smart’ toilet seat - The Boston Globe
Vertex Pharmaceuticals (NASDAQ:VRTX): An Affordable Growth Stock Balancing Strong Fundamentals With Reasonable Valuation - ChartMill
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by KBC Group NV - MarketBeat
Meeder Asset Management Inc. Buys 2,799 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Morgan Stanley Downgrades Vertex Pharmaceuticals to Equalweight From Overweight, Adjusts PT to $15 From $19 - marketscreener.com
Dimensional Fund Advisors LP Buys 43,682 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Baader Bank Aktiengesellschaft Sells 8,324 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Why Vertex Pharmaceuticals (VRTX) Dipped More Than Broader Market Today - Yahoo Finance
Vertex Pharmaceuticals Inc. stock underperforms Monday when compared to competitors - MarketWatch
Goldman Sachs Adjusts Price Target on Vertex Pharmaceuticals to $652 From $641, Maintains Buy Rating - Moomoo
Vertex Pharma stock trades near highs as cystic fibrosis portfolio drives double digit revenue growt - Ad-hoc-news.de
Vertex’s IgA nephropathy drug derisked after Novartis, Vera approvals - PharmaLive
WCM Investment Management LLC Has $496.93 Million Stock Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals (VRTX) Stock Analysis: A Healthcare Giant with 14% Upside Potential - DirectorsTalk Interviews
How FDA’s Pediatric Expansion of Casgevy at Vertex Pharmaceuticals (VRTX) Has Changed Its Investment Story - Yahoo Finance
Vertex Pharmaceuticals (VRTX) Wins FDA Nod To Treat Children As Young As 2 - Yahoo Finance
Vertex Pharmaceuticals just made a $10 billion acquisition worth watching - MSN
Vertex Pharmaceuticals Just Made a $10 Billion Acquisition Worth Watching - The Motley Fool
1.59%
1.17%
자본화:
|
볼륨(24시간):